Tokyo Tape
Sign in
← J Frontier

Quarterly report · Q3

2934.TEDINET S100QLF7
Period2022-06-01 → 2023-02-28
Filed2023-04-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 35
MetricValuePeriodScopeSource row
Revenue¥12.7bn2022-06-01 → 2023-02-28Cons.Net sales
Revenue¥11.9bn2021-06-01 → 2022-05-31Cons.Net sales (5-year summary)
Revenue¥7.4bn2021-06-01 → 2022-02-28Cons.Net sales
Operating income−¥690m2022-06-01 → 2023-02-28Cons.Operating income
Operating income¥575m2021-06-01 → 2022-02-28Cons.Operating income
Ordinary income−¥709m2022-06-01 → 2023-02-28Cons.Ordinary income
Ordinary income¥712m2021-06-01 → 2022-05-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥550m2021-06-01 → 2022-02-28Cons.Ordinary income
Profit before tax−¥710m2022-06-01 → 2023-02-28Cons.Income before income taxes
Profit before tax¥550m2021-06-01 → 2022-02-28Cons.Income before income taxes
Net income (owners)−¥604m2022-06-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income (owners)¥401m2021-06-01 → 2022-05-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥353m2021-06-01 → 2022-02-28Cons.Profit loss attributable to owners of parent
Net income−¥559m2022-06-01 → 2023-02-28Cons.Profit loss
Net income¥353m2021-06-01 → 2022-02-28Cons.Profit loss
Total assets¥7.8bnat 2023-02-28Cons.Assets
Total assets¥6.1bnat 2022-05-31Cons.Assets
Total assets¥5.5bnat 2022-02-28Cons.Total assets (5-year summary)
Total liabilities¥3.8bnat 2023-02-28Cons.Liabilities
Total liabilities¥1.9bnat 2022-05-31Cons.Liabilities
Net assets / equity¥4.0bnat 2023-02-28Cons.Net assets
Net assets / equity¥4.2bnat 2022-05-31Cons.Net assets
Net assets / equity¥4.1bnat 2022-02-28Cons.Net assets (5-year summary)
Cash and deposits¥2.4bnat 2023-02-28Cons.Cash and deposits
Cash and deposits¥3.0bnat 2022-05-31Cons.Cash and deposits
EPS (basic)¥-131.072022-06-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-54.372022-12-01 → 2023-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥90.642021-06-01 → 2022-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥80.62021-06-01 → 2022-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥43.282021-12-01 → 2022-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥86.682021-06-01 → 2022-05-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥76.332021-06-01 → 2022-02-28Cons.Diluted earnings per share (5-year summary)
Equity ratio48.3%at 2023-02-28Cons.Equity to asset ratio (5-year summary)
Equity ratio67.8%at 2022-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio73.5%at 2022-02-28Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 35
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-06-01 → 2023-02-28−¥139m
Reconciling Itemsreconcilingrevenue intersegment2022-06-01 → 2023-02-28−¥139m
Reconciling Itemsreconcilingsegment profit2022-06-01 → 2023-02-28−¥385m
jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segmentrevenue2022-06-01 → 2023-02-28¥4.0bn
jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segmentrevenue external2022-06-01 → 2023-02-28¥3.9bn
jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segmentrevenue intersegment2022-06-01 → 2023-02-28¥139m
jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segmentsegment profit2022-06-01 → 2023-02-28¥19m
jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segmentrevenue2022-06-01 → 2023-02-28¥3.0bn
jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segmentrevenue external2022-06-01 → 2023-02-28¥3.0bn
jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segmentsegment profit2022-06-01 → 2023-02-28¥252m
jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segmentrevenue2022-06-01 → 2023-02-28¥5.8bn
jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segmentrevenue external2022-06-01 → 2023-02-28¥5.8bn
jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segmentrevenue intersegment2022-06-01 → 2023-02-28¥458,000
jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segmentsegment profit2022-06-01 → 2023-02-28−¥576m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2023-02-28¥12.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2023-02-28¥12.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-06-01 → 2023-02-28¥139m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2023-02-28−¥305m
Reconciling Itemsreconcilingrevenue2021-06-01 → 2022-02-28−¥27m
Reconciling Itemsreconcilingrevenue intersegment2021-06-01 → 2022-02-28−¥27m
Reconciling Itemsreconcilingsegment profit2021-06-01 → 2022-02-28−¥270m
jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segmentrevenue2021-06-01 → 2022-02-28¥2.0bn
jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segmentrevenue external2021-06-01 → 2022-02-28¥2.0bn
jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segmentrevenue intersegment2021-06-01 → 2022-02-28¥27m
jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segmentsegment profit2021-06-01 → 2022-02-28¥45m
jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segmentrevenue2021-06-01 → 2022-02-28¥2.6bn
jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segmentrevenue external2021-06-01 → 2022-02-28¥2.6bn
jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segmentsegment profit2021-06-01 → 2022-02-28¥666m
jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segmentrevenue2021-06-01 → 2022-02-28¥2.9bn
jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segmentrevenue external2021-06-01 → 2022-02-28¥2.9bn
jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segmentsegment profit2021-06-01 → 2022-02-28¥134m
Total Of Reportable Segments And Otherssegment totalrevenue2021-06-01 → 2022-02-28¥7.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-06-01 → 2022-02-28¥7.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-06-01 → 2022-02-28¥27m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-06-01 → 2022-02-28¥845m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 342
ItemContextValueUnit
Operating incomePrior1YTDDuration575475000JPY
Operating incomeCurrentYTDDuration-690424000JPY
Interest income noiPrior1YTDDuration28000JPY
Interest income noiCurrentYTDDuration1024000JPY
Dividends income noiPrior1YTDDuration0JPY
Dividends income noiCurrentYTDDuration72000JPY
Subsidy income noi bountyPrior1YTDDuration－JPY
Subsidy income noi bountyCurrentYTDDuration2926000JPY
Other noiPrior1YTDDuration3250000JPY
Other noiCurrentYTDDuration1300000JPY
Non operating incomePrior1YTDDuration3278000JPY
Non operating incomeCurrentYTDDuration5323000JPY
Interest expenses noePrior1YTDDuration888000JPY
Interest expenses noeCurrentYTDDuration8931000JPY
Provision of allowance for doubtful accounts noePrior1YTDDuration828000JPY
Provision of allowance for doubtful accounts noeCurrentYTDDuration660000JPY
Stock issuance cost noePrior1YTDDuration25778000JPY
Stock issuance cost noeCurrentYTDDuration－JPY
Share acquisition rights issuance costs noePrior1YTDDuration－JPY
Share acquisition rights issuance costs noeCurrentYTDDuration9384000JPY
Other noePrior1YTDDuration1495000JPY
Other noeCurrentYTDDuration4927000JPY
Non operating expensesPrior1YTDDuration28991000JPY
Non operating expensesCurrentYTDDuration23903000JPY
Ordinary incomePrior1YTDDuration549763000JPY
Ordinary incomeCurrentYTDDuration-709004000JPY
Gain on reversal of subscription rights to shares eiPrior1YTDDuration2000JPY
Gain on reversal of subscription rights to shares eiCurrentYTDDuration－JPY
Extraordinary incomePrior1YTDDuration2000JPY
Extraordinary incomeCurrentYTDDuration－JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration－JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration907000JPY
Extraordinary lossPrior1YTDDuration－JPY
Extraordinary lossCurrentYTDDuration907000JPY
Income before income taxesPrior1YTDDuration549766000JPY
Income before income taxesCurrentYTDDuration-709912000JPY
Income taxes currentPrior1YTDDuration154696000JPY
Income taxes currentCurrentYTDDuration95567000JPY
Income taxes deferredPrior1YTDDuration42537000JPY
Income taxes deferredCurrentYTDDuration-246718000JPY
Income taxesPrior1YTDDuration197234000JPY
Income taxesCurrentYTDDuration-151151000JPY
Profit lossPrior1YTDDuration352531000JPY
Profit lossCurrentYTDDuration-558760000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration－JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration44870000JPY
Profit loss attributable to owners of parentPrior1YTDDuration352531000JPY
Profit loss attributable to owners of parentCurrentYTDDuration-603631000JPY
Profit lossPrior1YTDDuration352531000JPY
Profit lossCurrentYTDDuration-558760000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-05-31pass rounding
balance sheet identityconsolidated 2023-02-28pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-05-31pass
statement vs summary · net assetsconsolidated 2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2021-06-01/2022-02-28pass
statement vs summary · net income attributable to parentconsolidated 2022-06-01/2023-02-28pass
statement vs summary · revenueconsolidated 2021-06-01/2022-02-28pass
statement vs summary · revenueconsolidated 2022-06-01/2023-02-28pass
statement vs summary · total assetsconsolidated 2022-05-31pass
statement vs summary · total assetsconsolidated 2023-02-28pass